Since Bostrom et al. propose to explore the clinical uses of irisin in the treatment of obesity and diabetes, based on the fact that the expression of irisin improves glucose tolerance and decreases fasting insulin in mice [8], researchers from all over the world began to study the link between irisin and DM. This evidence concerns the gene FNDC5 and obesity disorder.